Stem Cell Transplantation: Curing Refractory Massive Heart Failure

Recently, the Department of Cardiology and Renal Medicine of Anning Branch of Lanzhou General Hospital of Lanzhou Military Region visited the first patient receiving cardiac stem cell therapy in our province. Surprisingly, the old man, who had suffered from severe refractory heart failure in large areas and was close to death, not only eliminated the manifestations of heart failure, but also improved the cardiac function significantly. The symptoms of diabetes, rheumatoid, tracheitis, etc., which had plagued him for many years, were also greatly alleviated.

According to the patient, three years ago, when he was treated in a foreign hospital, the doctor told him that his cardiovascular disease was serious and that he could not be operated on. With the last hope, he had a heart stent operation in the Department of Cardiology and Renal Medicine, Anning Branch of Lanzhou General Hospital, Lanzhou Military Region, and miraculously saved his life. But one year later, the heart disease recurred again. Chin Mian, director of Cardiology and kidney medicine of the hospital, did stem cell transplantation for him. Four months later, his condition of short breath was much better, and he did not wheeze when he spoke or walked. At present, patients with long-term treatment of diabetes, rheumatoid, tracheitis and other symptoms have also greatly improved. At the same time, in order to consolidate the curative effect and restore the body function, patients will receive stem cell therapy again in the near future.

Qin Mian, director of Cardiology and kidney medicine, said: "Stem cell transplantation, as a new method for the treatment of end-stage cardiovascular diseases, has become a hot topic in recent years. Its theoretical basis is to improve the almost exhausted pathological state of the heart by producing new cardiomyocytes and vascular endothelial cells, which is like injecting fresh force into the exhausted cardiomyocytes. As a new treatment method, there is still a lack of large sample clinical data, so we can not make a more objective and accurate evaluation of its long-term efficacy. However, according to the literature available at home and abroad and the first-hand clinical data we can grasp, the emergence of stem cell transplantation therapy can give patients a glimmer of light in the dark for the irreversible large-area damage of myocardium caused by massive myocardial infarction, the extensive myocardial damage caused by cardiomyopathy, and the patients with refractory and refractory heart failure.
Related News